A detailed history of Stockman Wealth Management, Inc. transactions in Compugen LTD stock. As of the latest transaction made, Stockman Wealth Management, Inc. holds 16,000 shares of CGEN stock, worth $28,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Previous 21,000 23.81%
Holding current value
$28,000
Previous $54,000 51.85%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$1.68 - $2.52 $8,400 - $12,600
-5,000 Reduced 23.81%
16,000 $26,000
Q4 2023

Feb 01, 2024

SELL
$0.53 - $2.0 $2,120 - $8,000
-4,000 Reduced 16.0%
21,000 $41,000
Q3 2023

Oct 31, 2023

SELL
$0.88 - $1.31 $11,616 - $17,292
-13,200 Reduced 34.55%
25,000 $23,000
Q2 2023

Aug 02, 2023

SELL
$0.57 - $1.38 $17,499 - $42,366
-30,700 Reduced 44.56%
38,200 $43,000
Q1 2023

May 04, 2023

SELL
$0.68 - $1.11 $1,292 - $2,109
-1,900 Reduced 2.68%
68,900 $48,000
Q4 2022

Feb 07, 2023

BUY
$0.58 - $1.2 $41,064 - $84,960
70,800 New
70,800 $50,000
Q2 2022

Jul 28, 2022

SELL
$1.57 - $3.33 $100,166 - $212,454
-63,800 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$14.16 - $19.45 $903,408 - $1.24 Million
63,800 New
63,800 $1.04 Million
Q2 2019

Aug 08, 2019

SELL
$2.8 - $4.14 $193,480 - $286,074
-69,100 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$2.35 - $4.19 $162,385 - $289,529
69,100 New
69,100 $286,000
Q3 2017

Nov 14, 2017

SELL
$2.75 - $3.95 $247,775 - $355,895
-90,100 Closed
0 $0
Q2 2017

Aug 09, 2017

BUY
N/A
90,100
90,100 $342,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $152M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Stockman Wealth Management, Inc. Portfolio

Follow Stockman Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stockman Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stockman Wealth Management, Inc. with notifications on news.